Reexamining a proposal

References

• Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 1957; 179:663 - 666; PMID: 13418758; http://dx.doi.org/10.1038/179663a0
   PubMed Web of Science ®Google Scholar
• Lokich J. Infusional 5-FU: historical evolution, rationale and clinical experience. [Williston Park]. Oncology 1998; 12:19 - 22; PMID: 9830620
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3:330 - 338; PMID: 12724731; http://dx.doi.org/10.1038/nrc1074
   PubMed Web of Science ®Google Scholar
• Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H, et al. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 1997; 15:389 - 400; PMID: 8996166
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355:11 - 20; PMID: 16822992; http://dx.doi.org/10.1056/NEJMoa055531
   PubMed Web of Science ®Google Scholar
• Noordhuis P, Holwerda U, Van der Wilt CL, Van Groeningen CJ, Smid K, Meijer S, et al. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann Oncol 2004; 15:1025 - 1032; PMID: 15205195; http://dx.doi.org/10.1093/annonc/mdh264
   PubMed Web of Science ®Google Scholar
• Brody JR, Hucl T, Costantino CL, Eshleman JR, Gallmeier E, Zhu H, et al. Limits to thymidylate synthase and Tp53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence. Cancer Res 2009; 69:984 - 991; PMID: 19155291; http://dx.doi.org/10.1158/0008-5472.CAN-08-3610
   PubMed Web of Science ®Google Scholar
• Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 1990; 48:381 - 395; PMID: 1707544; http://dx.doi.org/10.1016/01637258(90)90056-8
   PubMed Web of Science ®Google Scholar
• Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995; 20:191 - 197; PMID: 7586009; http://dx.doi.org/10.1247/csf.20.191
   PubMed Web of Science ®Google Scholar
• Luo HR, Lu XM, Yao YG, Horie N, Takeishi K, Jorde LB, et al. Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles. Biochem Genet 2002; 40:41 - 51; PMID: 11989786; http://dx.doi.org/10.1023/A:1014589105977
   PubMed Web of Science ®Google Scholar
• Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ, et al. A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 2003; 63:2898 - 2904; PMID: 12782596
   PubMed Web of Science ®Google Scholar
• de Bock CE, Garg MB, Scott N, Sakoff JA, Scorgie FE, Ackland SP, et al. Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo. Pharmacogenomics J
   PubMed Web of Science ®Google Scholar
• Kaneda S, Takeishi K, Ayusawa D, Shimizu K, Seno T, Altman S. Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Res 1987; 15:1259 - 1270; PMID: 3029702; http://dx.doi.org/10.1093/nar/15.3.1259
   PubMed Web of Science ®Google Scholar
• Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, et al. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 2001; 7:4096 - 4101; PMID: 11751507
   PubMed Web of Science ®Google Scholar
• Kawakami K, Watanabe G. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res 2003; 63:6004 - 6007; PMID: 14522928
   PubMed Web of Science ®Google Scholar
• Yawata A, Kim SR, Miyajima A, Kubo T, Ishida S, Saito Y, et al. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents. Cancer Chemother Pharmacol 2005; 56:465 - 472; PMID: 15918040; http://dx.doi.org/10.1007/s00280-005-1018-z
   PubMed Web of Science ®Google Scholar
• Ayusawa D, Shimizu K, Koyama H, Kaneda S, Takeishi K, Seno T. Cell cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate. J Mol Biol 1986; 190:559 - 567; PMID: 2431156; http://dx.doi.org/10.1016/0022-2836(86)90241-X
   PubMed Web of Science ®Google Scholar
• Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, et al. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 2001; 1:65 - 70; PMID: 11913730
   PubMedGoogle Scholar
• Lecomte T, Ferraz JM, Zinzindohoue F, Loriot MA, Tregouet DA, Landi B, et al. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer Res 2004; 10:5880 - 5888; PMID: 15355920; http://dx.doi.org/10.1158/1078-0432.CCR-04-0169
   PubMed Web of Science ®Google Scholar
• Ichikawa W, Takahashi T, Suto K, Sasaki Y, Hirayama R. Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen. Clin Cancer Res 2006; 12:3928 - 3934; PMID: 16818689; http://dx.doi.org/10.1158/10780432.CCR-05-2665
   PubMed Web of Science ®Google Scholar
• Schwab M, Zanger UM, Marx C, Schaeffeler E, Klein K, Dippon J, et al. Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. J Clin Oncol 2008; 26:2131 - 2138; PMID: 18299612; http://dx.doi.org/10.1200/JCO.2006.10.4182
   PubMed Web of Science ®Google Scholar
• Showalter SL, Showalter TN, Witkiewicz A, Havens R, Kennedy EP, Hucl T, et al. Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?. Cancer Biol Ther 2008; 7:986 - 994; PMID: 18443433; http://dx.doi.org/10.4161/cbt.7.7.6181
   PubMed Web of Science ®Google Scholar
• Lyss AP, Lilenbaum RC, Harris BE, Diasio RB. Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity. Cancer Invest 1993; 11:239 - 240; PMID: 8462026; http://dx.doi.org/10.3109/07357909309024846
   PubMed Web of Science ®Google Scholar
• Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, et al. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 1998; 4:2371 - 2376; PMID: 9796967
   PubMed Web of Science ®Google Scholar
• Grem JL. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs 2000; 18:299 - 313; PMID: 11081567; http://dx.doi.org/10.1023/A:1006416410198
   PubMed Web of Science ®Google Scholar
• Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase and thymidine phosphorylase. Clin Cancer Res 2000; 6:1322 - 1327; PMID: 10778957
   PubMed Web of Science ®Google Scholar
• Fujii R, Seshimo A, Kameoka S. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl-transferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 2003; 8:72 - 78; PMID: 12720098; http://dx.doi.org/10.1007/s101470300013
   PubMedGoogle Scholar
• Kornmann M, Schwabe W, Sander S, Kron M, Strater J, Polat S, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res 2003; 9:4116 - 4124; PMID: 14519634
   PubMed Web of Science ®Google Scholar
• Kakimoto M, Uetake H, Osanai T, Shirota Y, Takagi Y, Takeshita E, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test. Cancer Lett 2005; 223:103 - 111; PMID: 15890242; http://dx.doi.org/10.1016/j.canlet.2004.09.020
   PubMed Web of Science ®Google Scholar
• Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349:247 - 257; PMID: 12867608; http://dx.doi.org/10.1056/NEJMoa022289
   PubMed Web of Science ®Google Scholar
• BioMed Crit Comm 2011; 4:2417
   Google Scholar
• Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525 - 532; PMID: 2841597; http://dx.doi.org/10.1056/NEJM198809013190901
   PubMed Web of Science ®Google Scholar
• Kawakami K, Ishida Y, Danenberg KD, Omura K, Watanabe G, Danenberg PV. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity. Jpn J Cancer Res 2002; 93:1221 - 1229; PMID: 12460463
   PubMedGoogle Scholar
• Villafranca E, Okruzhnov Y, Dominguez MA, Garcia-Foncillas J, Azinovic I, Martinez E, et al. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol 2001; 19:1779 - 1786; PMID: 11251009
   PubMed Web of Science ®Google Scholar
• Brody JR, Hucl T, Gallmeier E, Winter JM, Kern SE, Murphy KM. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy. Cancer Res 2006; 66:9369 - 9373; PMID: 17018589; http://dx.doi.org/10.1158/0008-5472.CAN06-2165
   PubMed Web of Science ®Google Scholar
• Wang TL, Diaz L Jr, Romans K, Bardelli A, Saha S, Galizia G, et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci USA 2004; 101:3089 - 3094; PMID: 14970324; http://dx.doi.org/10.1073/pnas.0308716101
   PubMed Web of Science ®Google Scholar
• Kozak M. Comparison of initiation of protein synthesis in procaryotes, eucaryotes and organelles. Microbiol Rev 1983; 47:1 - 45; PMID: 6343825
   PubMedGoogle Scholar
• Coonrod A, Li FQ, Horwitz M. On the mechanism of DNA transfection: efficient gene transfer without viruses. Gene Ther 1997; 4:1313 - 1321; PMID: 9472555; http://dx.doi.org/10.1038/sj.gt.3300536
   PubMed Web of Science ®Google Scholar
• Santi DV, McHenry CS. 5-Fluoro-2′-deoxyuridylate: covalent complex with thymidylate synthetase. Proc Natl Acad Sci USA 1972; 69:1855 - 1857; PMID: 4505665; http://dx.doi.org/10.1073/pnas.69.7.1855
   PubMed Web of Science ®Google Scholar